We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
Cap. Flow
-$138M
Cap. Flow %
-2.91%
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$253M
2
PDCE
PDC Energy, Inc.
PDCE
+$210M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$206M
4
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$135M
5
LSI
Life Storage, Inc.
LSI
+$87.5M

Top Sells

Rank Stock Value
1
FHN icon
First Horizon
FHN
+$179M
2
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
+$146M
3
PRVB
Provention Bio, Inc. Common Stock
PRVB
+$70.5M
4
TSEM icon
Tower Semiconductor
TSEM
+$50.8M
5
XM
Qualtrics International Inc. Class A Common Stock
XM
+$45.3M

Sector Composition

Rank Sector Weight
1 Healthcare 32.35%
2 Technology 15.53%
3 Financials 11.99%
4 Real Estate 8.48%
5 Materials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRVL icon
376
Marvell Technology
MRVL
$189B
$897K 0.02%
+15,000
New +$729K
OSI
377
DELISTED
Osiris Acquisition Corp.
OSI
$877K 0.02%
80,570
-1,816
-2% -$18.1K
XFOR icon
378
X4 Pharmaceuticals
XFOR
$393M
$873K 0.02%
+15,000
New +$771K
INBX
379
DELISTED
Inhibrx, Inc. Common Stock
INBX
$868K 0.02%
33,448
+1,648
+5% +$38.5K
INZY
380
DELISTED
Inozyme Pharma
INZY
$865K 0.02%
155,305
+7,651
+5% +$45.2K
AMLX icon
381
Amylyx Pharmaceuticals
AMLX
$2.7B
$841K 0.02%
+39,000
New +$1.05M
MORF
382
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$839K 0.02%
14,635
-15,917
-52% -$831K
ATVI
383
CALL
DELISTED
Activision Blizzard
ATVI
$825K 0.02%
506,300
-27,400
-5% -$2.22M
RH icon
384
RH
RH
$3.56B
$824K 0.02%
+2,500
New +$653K
BHAC
385
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
$819K 0.02%
78,575
-2,557
-3% -$26.4K
AMC icon
386
PUT
AMC Entertainment Holdings
AMC
$2.29B
$811K 0.02%
+35,000
New +$1.73M
CRC icon
387
California Resources
CRC
$4.67B
$770K 0.02%
17,004
-955
-5% -$38.8K
DBTX
388
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$767K 0.02%
199,200
+9,814
+5% +$36K
QTRX icon
389
Quanterix
QTRX
$180M
$767K 0.02%
+34,000
New +$606K
IRON icon
390
Disc Medicine
IRON
$2.97B
$760K 0.02%
17,121
-28,629
-63% -$1.02M
ACRS icon
391
Aclaris Therapeutics
ACRS
$851M
$757K 0.02%
73,014
-10,664
-13% -$96.5K
PHM icon
392
Pultegroup
PHM
$24.7B
$733K 0.02%
9,441
-48,152
-84% -$3.26M
DHI icon
393
D.R. Horton
DHI
$40.8B
$728K 0.02%
+5,985
New +$654K
ZTO icon
394
ZTO Express
ZTO
$18.3B
$722K 0.02%
28,800
-53,558
-65% -$1.47M
SDGR icon
395
Schrodinger
SDGR
$1.33B
$709K 0.01%
14,200
-3,881
-21% -$131K
XRX icon
396
PUT
Xerox
XRX
$424M
$709K 0.01%
248,800
– –
DTIL icon
397
Precision BioSciences
DTIL
$205M
$704K 0.01%
44,610
+14,082
+46% +$322K
GLUE icon
398
Monte Rosa Therapeutics
GLUE
$1.33B
$688K 0.01%
100,478
+4,950
+5% +$32K
ITOS
399
DELISTED
iTeos Therapeutics
ITOS
$685K 0.01%
51,764
-17,536
-25% -$250K
VKTX icon
400
Viking Therapeutics
VKTX
$3.88B
$679K 0.01%
41,905
-23,703
-36% -$497K
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q2 2023 Portfolio in Review

As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.

  • UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
  • UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
  • UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
  • UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
  • UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
  • UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
  • UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.

Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.